[Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring
B E
BE
Vasil'ev
A V
AV
Sakharova
I Ia
IIa
Machkova
N A
NA
Ivanova
L A
LA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D010455:Peptides / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D013949:Thymus Extracts / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*; D014373:Tuberculin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000276:immunology*
D000276:Adjuvants, Immunologic; D007136:Immunoglobulins; D010455:Peptides; D013949:Thymus Extracts; D013951:Thymus Hormones; D014373:Tuberculin; C032805:thymalin; C036191:T-activin
Immunologicheskie kriterii primeneniia preparatov timusa i tuberkulinoterapii v kompleksnoĭ terapii bol'nykh tuberkulezom.